Novel Adjuvant for a Malaria Vaccine
$450,000N01FY2018AINIH
Versatope Therapeutics, Inc., Lowell MA
Investigators
Abstract
This proposal aims to develop a malaria transmission blocking vaccine candidate.
View original record on NIH RePORTER →Versatope Therapeutics, Inc., Lowell MA
This proposal aims to develop a malaria transmission blocking vaccine candidate.
View original record on NIH RePORTER →